H.M.U. Peulen

Research output

Research output per year 2017 2017 2019 2021 2022 2024 2024

• 6 Article
• 1 Phd-Thesis - Research and graduation internal

Research output per year

Research output per year

Search results

• 2024

  Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohorts

  van Geffen, E. G. M., Langhout, J. M. A., Hazen, S. J. A., Sluckin, T. C., van Dieren, S., Beets, G. L., Beets-Tan, R. G. H., Borstlap, W. A. A., Burger, J. W. A., Horsthuis, K., Intven, M. P. W., Aalbers, A. G. J., Havenga, K., Marinelli, A. W. K. S., Melenhorst, J., Nederend, J., Peulen, H. M. U., Rutten, H. J. T., Schreurs, W. H., Tuynman, J. B., & 6 othersVerhoef, C., de Wilt, J. H. W., Marijnen, C. A. M., Tanis, P. J., Kusters, M. & on behalf of the Dutch Snapshot Research Group, 1 May 2024, In: European Journal of Cancer. 202, 114021.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
• 2022

  Development of a consensus-based delineation guideline for locally recurrent rectal cancer

  Piqeur, F., Hupkens, B. J. P., Nordkamp, S., Witte, M. G., Meijnen, P., Ceha, H. M., Berbee, M., Dieters, M., Heyman, S., Valdman, A., Nilsson, M. P., Nederend, J., Rutten, H. J. T., Burger, J. W. A., Marijnen, C. A. M. & Peulen, H. M. U., 1 Dec 2022, In: Radiotherapy and oncology. 177, p. 214-221 8 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  1 Citation (Scopus)

• Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)

  van den Berg, K., Schaap, D. P., Voogt, E. L. K., Buffart, T. E., Verheul, H. M. W., de Groot, J. W. B., Verhoef, C., Melenhorst, J., Roodhart, J. M. L., de Wilt, J. H. W., van Westreenen, H. L., Aalbers, A. G. J., van 't Veer, M., Marijnen, C. A. M., Vincent, J., Simkens, L. H. J., Peters, N. A. J. B., Berbée, M., Werter, I. M., Snaebjornsson, P., & 10 othersPeulen, H. M. U., van Lijnschoten, I. G., Roef, M. J., Nieuwenhuijzen, G. A. P., Bloemen, J. G., Willems, J. M. W. E., Creemers, G. J. M., Nederend, J., Rutten, H. J. T. & Burger, J. W. A., Dec 2022, In: BMC Cancer. 22, 1, p. 957 1 p., 957.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  3 Citations (Scopus)
• 2021

  Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: Study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II)

  PelvEx Collaborative, 1 May 2021, In: BJS Open. 5, 3, zrab029.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  13 Citations (Scopus)
• 2019

  Effect of Pembrolizumab after Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients with Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial

  Theelen, W. S. M. E., Peulen, H. M. U., Lalezari, F., van der Noort, V., de Vries, J. F., Aerts, J. G. J. V., Dumoulin, D. W., Bahce, I., Niemeijer, A-L. N., de Langen, A. J., Monkhorst, K. & Baas, P., 1 Sept 2019, In: JAMA Oncology. 5, 9, p. 1276-1282 7 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  620 Citations (Scopus)

• Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib

  De Haan, R., Van Werkhoven, E., Peulen, H. M. U., Sonke, G. S., Elkhuizen, P., Van Den Brekel, M. W. M., Tesselaar, M. E. T., Vens, C., Schellens, J. H. M., Van Triest, B., Verheij, M. & van den Heuvel, M. M., 10 Sept 2019, In: BMC Cancer. 19, 1, 13 p., 901.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  31 Citations (Scopus)